Background:T wave positivity in the lead aVR is a marker of ventricular
repolarization abnormality and provides information on short and
long-term cardiovascular mortality in patients who have heart failure,
anterior myocardial infarction, and receive hemodialysis for various
reasons. The aim of this study was to investigate the relationship
between T wave positivity in the lead aVR on superficial ECG and
mortality from COVID-19 pneumonia. Methods: This study retrospectively
included 130 patients who were diagnosed with COVID-19 and treated as an
outpatient or in the thoracic diseases ward in a single center between
January 2021 and June 2021. All patients included in the study had
clinical and radiological features and signs of COVID-19 pneumonia. The
COVID-19 diagnosis of all patients was confirmed by polymerase chain
reaction (PCR) studied from an oropharyngeal swab Results: A total of
130 patients were included in this study. Patients were divided into 2
groups: survived and deceased. There were 55 patients (with a mean age
of 64.76-14.93 years, 58.18% male, 41.12% female) in the survived
group, while there were 75 patients (with a mean age of 65-15 years,
58.67% male, 41.33% female) in the deceased group. The univariate and
multivariate regression analyses showed that positive TAVR (OR: 5.151,
95% CI: 1.001-26.504, p: 0.0012), lactate dehydrogenase (LDH) (OR:
1.006, 95% CI: 1.001-1.010, p: 0.012) and D-dimer (OR:1.436, 95% CI:
1.115-1.848, p: 0.005) were independent risk factors for mortality
Conclusions: positive TAaVR is useful in risk stratification for
COVID-19 pneumonia mortality. KEY WORLD:Electrocardıographıa, positive
TAaVR, COVID-19 pneumonia, mortality